Maryland New Patient Packet Logo
  • Maryland New Patient Packet

  •  - -
  • Patient Confidentiality Agreement

  • BrightView is a confidential counseling service. BrightView is bound by State and Federal laws of confidentiality of both mental health and substance use disorder services. Once an appointment is made, no information can be disclosed to anyone without your written permission on a Release of Information Form. During your first appointment, the policy on confidentiality and your rights as a patient will be discussed in detail.

     

    What this means for you:

    BrightView will not share your information with a third-party without your written consent. BrightView staff will work diligently to protect information provided in counseling sessions.

     

    • Confidentiality does not apply to cases of reported or suspected abuse/neglect of children or the elderly.
    • Confidentiality does not apply to cases of potential harm to self or others.
    • In cases of medical emergency, information may be shared with medical personnel.
    • On rare occasions, there will be a request by a court for your records. BrightView may be required to share that information. BrightView will make an effort to discuss with you any instances where your confidentiality may be breached. BrightView will make an effort to share only information which is deemed legally necessary.
    • Information must be shared with your insurance provider, should you choose to use insurance. This information may be seen by various employees of the insurance provider. There is also potential that certain members of your employer may see this information.


    Your Responsibility:

    It is also your responsibility to protect the confidentiality of other patients. Do not discuss other patients (names, diagnoses, etc.) outside of group therapy sessions. In order to protect your confidentiality, all patients must agree to honor this policy as well. If you are found to have breached this confidentiality policy, you may be discharged from the program.

     

    By consenting, you acknowledge that there may be instances where BrightView must share your confidential information and you recognize that you are responsible for helping maintain the confidentiality of other patients. Discussing other patients outside of the group sessions may result in your termination from the program.

  • Clear
  • Consent for Alcohol or Drug Assessment and Treatment

  • I understand that as a patient of BrightView I am eligible to receive a range of services. The type and extent of services that I will receive will be determined following an initial assessment and thorough discussion with me. The goal of the assessment process is to determine the best course of treatment for me. Typically, treatment is provided over the course of several months.

     

    1. Consent to Evaluate/Treat: I voluntarily consent that I will participate in an alcohol or drug assessment and/or treatment by staff from BrightView. I understand that following the assessment and/or treatment, complete and accurate information will be provided concerning each of the following areas:

     

    • The benefits of the proposed treatment.
    • Alternative treatment modes and services
    • The manner in which treatment will be administered
    • Expected side effects from the treatment and/or the risks of side effects from medications (when applicable)
    • Probable consequences of not receiving treatment


    Treatment will be conducted within the boundaries of Maryland substance use disorder treatment laws. I understand that a range of mental health professionals, some of whom are in training, provides BrightView services. All professionals-in-training are supervised by licensed staff.

     

    2. Benefits and Risks to Assessment/Treatment: Assessment and treatment may be administered with psychological interviews, psychological assessment or testing, psychotherapy, medication management, as well as expectations regarding the length and frequency of treatment. It may be beneficial to me, as well as the referring professional, to understand the nature and cause of any difficulties affecting my daily functioning, so that appropriate recommendations and treatments may be offered. Uses of this assessment include diagnosis, assessment of recovery or treatment, estimating prognosis, and education and rehabilitation planning.

    Possible benefits to treatment include improved cognitive or academic/job performance, health status, quality of life, and awareness of strengths and limitations. I understand that while psycho- therapy and/or medication may provide significant benefits, it may also pose risks. Psychotherapy may elicit uncomfortable thoughts and feelings or may lead to the recall of troubling memories. I realize that sometimes medications may have unwanted side effects.

     

    3. Research: As part of ongoing client satisfaction surveys and future research some information from your file may be submitted to third parties or utilized by BrightView. Your identifying information will not be shared, however, general information (age, race, and sex) may be shared.

     

    4. Charges: Fees are based on the length or type of the assessment or treatment, which are determined by the nature of the service. I will be responsible for any charges not covered by insurance, including co-payments and deductibles. Fees are available to me upon request.

     

    5. Confidentiality: Information from my assessment and/or treatment is contained in a confidential medical record at BrightView. I understand that BrightView will obtain my photograph for the purpose of providing me with a BrightView identification card. This same photograph will be stored electronic health records as a primary form of my identification. The purpose of these photos is to be in compliance with BrightView’s policy and procedures of using two forms of identification to recognize each client.

     

    I understand surveillance cameras are located throughout BrightView for routine observation. 

     

    6. Right to Withdraw Consent: I have the right to withdraw my consent for assessment and/or treatment at any time by providing a written request to the treating clinician.

     

    7. General Laboratory Testing and Reporting: Laboratory testing, including, but not limited to blood work, may be requested. This testing may be to identify diagnosis of HIV, Hepatitis B or C, or other bloodborne disease. Positive results from this lab work must be reported to the appropriate authorities. I authorize BrightView to disclose any reportable infectious disease and information regarding that infectious disease to my local and state health department for purposes of coordinating care. Only the minimum amount of protected health information needed to accomplish the intended purpose of the use is permitted for these disclosures.

     

    I understand that my alcohol and/or drug abuse treatment records are protected under federal regulations 42 C.F.R. Part 2 - Confidentiality of Alcohol and Drug Abuse Patient Records and cannot be disclosed without my written consent. I may revoke this consent in writing at any time. I understand that the revocation will not be effective retroactively for information disclosures that have already occurred. If not previously revoked, this consent will remain valid 90 days after discharge.

     

    8. Toxicology Testing: I understand that upon admission and throughout my course of treatment, I will be required to submit to a variety of toxicology tests to include urine drug testing, alcohol testing, pregnancy testing (if applicable), and blood/lab work testing. The treatment team and provider will determine the frequency of these tests. I give my consent to undergo all tests described above as they apply to me. I further give my consent to allow BrightView to send my urine specimen to the laboratory for analysis.

     

    9. Expiration of Consent: This informed consent document will be valid for the length of the patient's treatment.

     

    10. Informed Consent for Medication Assisted Treatment: In accordance with evidence-based practices, BrightView, upon assessment and evaluation and at the recommendation of a medical provider may prescribe various medications to patients in recovery. These medications are used in conjunction with group counseling, individual counseling, and family counseling. Any medication I receive may have an adverse reaction and/or possible side effects.

     

    The goal of medication assisted treatment is to stabilize functioning. I realize that for some patients’ treatment may continue for relatively long periods of time, but that periodic consideration shall be given concerning my complete withdrawal from the use of all drugs.

    11. Treatment with Buprenorphine (if applicable):

    Buprenorphine is an FDA approved medication for the treatment of opioid addiction. Buprenorphine can be used for detoxification or for maintenance therapy. Maintenance therapy can continue as long as medically necessary. There are other treatments for opiate addiction, including methadone, naltrexone, and some treatments without medications. The appropriate treatment plan for you will be determined by your primary counselor and a physician.

     

    Use of buprenorphine will maintain your physical dependence. If you discontinue it suddenly, you will likely experience withdrawal. If you are not already dependent, you should not take buprenorphine as it could eventually cause physical dependence. The medication you will be taking will likely contain both buprenorphine and an opiate blocker (naloxone). If the medication is abused by snorting or injection, the naloxone will cause severe withdrawal but when taken as directed, the naloxone has no effect.

     

    If you are dependent on opioids you should be in as much withdrawal as possible when you take the first dose of buprenorphine/ naloxone. If you are not in withdrawal, buprenorphine/ naloxone can cause severe opiate withdrawal. We recommend that you arrange not to drive after your first dose, because some patients may experience drowsiness during the early phases of treatment. It may take several days to feel completely comfortable with the transition to buprenorphine/naloxone.

     

    Combining buprenorphine with alcohol or other sedating medications is dangerous. The combination of buprenorphine with benzodiazepines (such as Valium®, Librium®, Ativan®, Xanax®, Klonopin®, etc.) has resulted in deaths. Although sublingual buprenorphine has not been shown to be liver-damaging, your doctor will monitor your liver tests while you are taking buprenorphine. (This is a blood test.) Attempts to override the buprenorphine by taking more opioids could result in an opioid overdose. You should not take any other medication without discussing it with the physician first.

     

    I understand that buprenorphine products and other medication assisted treatment medications may interact with other prescription medications, vitamins and nutritional supplements. Potential interactions include increasing or decreasing the level of buprenorphine products in my body or, in extremely rare instances, possibly causing an abnormal heart rhythm that has the potential
    to be lethal. I agree that it is my responsibility to provide documentation of all medication, vitamins and nutritional supplements I am taking on at least a monthly basis.

     

    I understand that I may withdraw from this treatment and discontinue when indicated the use of the medication at any time, and I shall be afforded medical withdrawal under medical supervision. The medically supervised withdrawal could be either a short-term withdrawal or long-term withdrawal. This will be at the discretion of the Medical Director/Provider. I understand that once I complete a medically supervised withdrawal, I may be offered an aftercare program which will include counseling only.

     

    I have read and understand these details about medication assisted treatment, including risks and benefits. I understand there are alternatives and wish to be treated with buprenorphine if that is medication that the physician deems medically appropriate.

    I have read and understand these details about medication assisted treatment, including risks and benefits. I understand there are alternatives and wish to be treated with buprenorphine if that is medication that the physician deems medically appropriate.

    12. Treatment with Methadone (if applicable):
    I understand that I have been diagnosed as suffering from opioid dependence (i.e. that I am or have been addicted to an opiate drug, such as heroin or oxycodone) and that it has further been determined that an appropriate treatment is opioid maintenance therapy, which involves the daily use of medication (methadone), along with medical and rehabilitative (counseling) services, to alleviate the adverse medical, psychological, or physical effects incident to opiate addiction. The overall goal of opioid maintenance therapy is improved quality of life and freedom from
    illicit drugs.

    I understand that methadone does not cure addiction, and is itself an opioid drug, which is addictive and can have serious, even fatal, side effects. The most commonly reported side effects are constipation and sweating/flushing. It may also cause dizziness, especially after sitting or lying down; drowsiness; mood changes; vision problems; difficulty falling or staying asleep; and sexual side effects. Serious and sometimes fatal side effects include seizures; severe allergic reaction; slowed or difficult breathing; and irregular heartbeat, especially in patients with certain existing heart conditions (known as prolonged QT interval).

    I understand that mixing methadone with other depressants (such as alcohol or benzodiazepines) is especially dangerous and will refrain from doing so. I agree to take methadone only as prescribed, and to inform other healthcare providers that I take methadone to avoid potentially harmful interactions. Until I know how methadone will affect me, I will use caution when driving or operating machinery. I have made the Medical Director/Provider aware of all medical conditions I have and medications (prescription, over-the-counter, or illicit) I take, and will keep this
    information current throughout treatment.

    I understand that methadone maintenance therapy generally takes place over an extended period of time, but that I am free to discontinue treatment at any time. I understand that if I stop taking methadone suddenly that it may produce severe withdrawal symptoms. I understand that at periodic intervals, and with my full consultation, the Program will discuss my present level of functioning, my course of treatment, and my future goals.

    I understand that all medical decisions, including, but not limited to, diagnosis and treatment, are made by the Medical Director/ Provider, and hereby release the Program from any and all liability arising from such decisions.

    I understand that other treatments are available, including, but not limited to, inpatient treatment, detoxification programs, buprenorphine treatment, and abstinence programs

     

    13. Opiate Treatment Program (OTP) (if applicable)

    I agree that I shall inform any doctor who may treat me for any medical problem that I am enrolled in a substance use disorder treatment program, since the use of other medications in conjunction with medication assisted treatment prescribed by the treatment program may cause me harm. In addition, I agree that I am not currently enrolled in another OTP at this time.

    I understand State and Federal law prohibits dual enrollment in opiate treatment programs. I therefore give my consent to allow BrightView to disclose my enrollment status, via fax or verbal confirmation, to all opiate treatment programs in accordance with state and federal law guidelines. I further give my consent to allow BrightView to disclose my enrollment status, via fax, electronic transfer or verbal confirmation, to any other OTP within a 50-mile radius.

    I hereby certify that no guarantee or assurance has been made as to the results that may be obtained from alcohol and drug treatment. With full knowledge of the potential benefits and possible risks involved, I consent to assessment and treatment.

  • Clear
  • Consent for BrightView Medication Adherence

  • Medication adherence simply means sticking to the medication prescribed/ordered for you. Adhering to medication is also taking the medication as directed by a health care professional - whether taken in pill form, inhaled, injected, or applied topically.

     

    Not taking medication as prescribed is called non-adherence. Many people never fill their medications, or they may never pick up their filled prescriptions from the pharmacy. Other people bring their medication home, but don’t follow their health care professional’s instructions - they skip doses or stop taking the medicine.

     

    Specifically, non-adherence includes:

     

    • Not filling a new medication or refilling an existing medication when you are supposed to.
    • Stopping a medicine before the instructions say you should.
    • Taking more or less of the prescribed/ordered medicine; or at the wrong time of day.


    Often there is no single reason someone does not take their medicine as directed, but rather a combination of reasons. One person may face different barriers at different times as he or she manages his or her condition. Whatever the reason, the result is always the same - patients miss out on life -saving benefits, a better quality of life, and lose protection against future illness or serious health complications.

    All medicines have risks and benefits. When a patient works with their health care professional to decide to use medicine to help manage a long-term health condition, he or she accepts certain risks in exchange for potential health benefits. Consumers can help manage those risks by using medicines safely, including storing & disposing of them safely.

     

    Importance of Medication Adherence Specifically at BrightView:

    Some of the medications prescribed at BrightView are controlled substances which have an increased requirement for compliance from patients. This is very important because of the health and possible legal consequences associated.

     

    • All patients must take medication EXACTLY as prescribed/ordered
      • Do not attempt to adjust the dose of your medication up or down without consultation of your physician.

    • Keep medications in a safe and secure location.Theft of medication will not result in an early refill.

    • If you have any questions concerning medication, set up an appointment with the nurse practitioner/physician.

    • Because of the medication you are taking and a history of substance abuse, it is vital that you coordinate your other medical appointments or surgical/dental procedures that you have with BrightView. Plan ahead.

    • It is important that you tell your primary care physician or any other physician who writes a prescription that you are receiving treatment services at BrightView.

    • DO NOT EVER SELL YOUR MEDICATION OR TRY TO BUY MEDICATION FROM SOMEONE. THIS WILL LIKELY RESULT IN IMMEDIATE DISMISSAL FROM THE PROGRAM AND CAN RESULT IN LEGAL CONSEQUENCES FOR YOU.

    • NON-ADHERENCE WITH YOUR MEDICATION REGIMEN CAN ALSO RESULT IN RESTRICTIONS BY YOUR INSURANCE COMPANY THAT CANNOT BE RESOLVED BY THE TEAM AT BRIGHTVIEW. YOU MAY LOSE THE ABILITY TO GET YOUR MEDICATIONS PAID FOR BY INSURANCE.

    • BRING ALL MEDICATIONS PRESCRIBED BY BRIGHTVIEW PROVIDERS TO EVERY MEDICAL APPOINTMENT.
  • Clear
  • Mutual Expectations: Patient and Team Agreement

  • By following our values of Respect, Inspiration, Service, and Excellence, we make sure everyone at our center — both center team members and patients — treats each other with kindness and respect. This helps us create a place where everyone feels safe and cared for, where best medical care is given, to build a strong community focused on healing and recovery.

    Respect

    Everyone at our center, including staff and patients, agrees to treat each other kindly and with respect. We value everyone’s time and make sure to communicate well. This means we keep our place clean and safe, and we're always ready and there for each other.


    Patients should: Be on time for appointments, follow the rules of the facility, and treat center team members kindly.


    Center Team will: CCare for patients with kindness. Listen carefully to what patients say. Make sure everyone feels welcomed.

     

    Inspiration

    We all help create positive experiences at our center. We support each other's growth and healing.

    Patients should: Engage in treatment actively, share positive experiences, and celebrate personal milestones.

    Center Team will: Encourage patients. Notice and praise patients' improvements.

     

    Service

    We work fast to take care of patients’ needs and make sure we talk clearly with them about their treatment.

    Patients should: Clearly say what they need, take part in all planned activities, and follow the treatment plan.

    Center Team will: Quickly respond to patients' needs, keep in touch with patients clearly and regularly, and help patients follow
    their care plans.

     

    Excellence

    We all follow the best and latest ways to provide care. We keep learning and doing our best.

    Patients should: Follow their treatment plans and work on getting better.

    Center Team will: Keep learning new things, follow the best ways to provide care, and always act professionally and honestly

     

  • Clear
  • Consent to Receive Emails

  • As a patient of BrightView, it is important that we be able to contact your using your email to remind you of appointments, to obtain your feedback on your experience with our healthcare team, to obtain feedback for marketing purposes and to provide you with advertisements or telemarketing messages.

     

    By entering your email below, you authorize BrightView, its employees and its agents, to send emails to that address. You agree that we may use your email address to send you information, including healthcare information, advertisements and telemarketing messages.

     

    BrightView does not charge for these services.

     

    You are not required to provide this consent in order to receive services from BrightView.

     

    You may revoke this consent at any time by providing us with notice that you no longer want to receive these communications by replying “STOP” to any email you receive from us.
     

  • Clear
  • Consent to Text Messages and Calls

  • As a patient of BrightView, it is important that we be able to contact your using your wireless telephone to remind you of appointments, to obtain your feedback on your experience with our healthcare team, to obtain feedback for marketing purposes and to provide you with advertisements or telemarketing messages. We may use an automatic telephone dialing system or an artificial or pre- recorded voice to deliver these messages to you.

     

    By entering your wireless telephone number below, you authorize BrightView, its employees and its agents, to send text messages, and make telephone calls to that number. You agree that we may use your wireless telephone number to send you information, including healthcare information, advertisements and telemarketing messages. You also understand that we may use an automatic telephone dialing system or an artificial or pre-recorded voice to deliver these messages to your wireless telephone number.

     

    BrightView does not charge for these services, but regular text messaging or incoming call rates may apply. Contact your carrier for pricing plans and details.

     

    You are not required to provide this consent in order to receive services from BrightView.

     

    You may revoke this consent at any time by providing us with notice that you no longer want to receive these communications via your wireless telephone, or by replying “STOP” to any text message.

  • Clear
  • Consent to the Use of Telemedicine

  • Telemedicine involves the use of electronic communications to enable health care providers at different locations to share individual patient medical information for the purpose of improving patient care.

     

    Providers may include practitioners, specialists, and/or subspecialists. The information may be used for diagnosis, treatment, follow-up and/or education, and may include any of the following:

     

    • Patient medical records
    • Live two-way audio and video
    • Output data from medical devices and sound and video files


    Electronic systems used will incorporate network and software security protocols to protect the confidentiality of patient identification and medical data and will include measures to safeguard data to ensure its integrity against intentional or unintentional corruption.

     

    Expected Benefits:

     

    • Improved access to medical care by enabling a patient to remain in a clinical setting (or at a remote site) while the practitioner obtains test results and consults from healthcare practitioners at distant/other sites.
    • More efficient medical evaluation and management.
    • Obtaining expertise of a distant specialist.


    Possible Risks:

     

    As with any medical procedure, there are potential risks associated with the use of telemedicine. These risks include, but may not be limited to:

     

    Clinical Considerations:

     

    • In rare cases, information transmitted may not be sufficient (e.g. poor resolution of images) allow for appropriate medical decision making by the physician and consultant(s);
    • Delays in medical evaluation and treatment could occur due to deficiencies or failures of the equipment;
    • In rare cases, a lack of access to complete medical records may result in adverse drug interactions or allergic reactions or other judgment errors;


    Security Considerations:

     

    In very rare instances, security protocols could fail, causing a breach of privacy of personal medical information;


    Confidentiality Considerations:

     

    If people are close to you, they may hear something you did not want them to know. You should be in a private place, so other people cannot hear you.
    Your provider will tell you if someone else from their office can hear or see you.


    By accepting, I understand the following:

     

    1. I understand that the laws that protect privacy and the confidentiality of medical information also apply to telemedicine, and that no information obtained in the use of telemedicine which identifies me will be disclosed to researchers or other entities without my consent.
    2. I understand that I have the right to withhold or withdraw my consent to the use of telemedicine in the course of my care at any time, without affecting my right to future care or treatment.
    3. I understand that a variety of alternative methods of medical care may be available to me, and that I may choose one or more of these at any time. My practitioner has explained the alternatives to my satisfaction.
    4. I understand that telemedicine may involve electronic communication of my personal medical information to other medical practitioners who may be located in other areas.
    5. I understand that it is my duty to inform my practitioner of electronic interactions regarding my care that I may have with other healthcare providers.
    6. I understand that I may expect the anticipated benefits from the use of telemedicine in my care, but that no results can be guaranteed or assured.


    I have read and understand the information provided above regarding telemedicine, have discussed it with my practitioner or other treatment providers as designated, and all of my questions have been answered to my satisfaction. I hereby give my informed consent for the use of telemedicine in my medical care.

  • Clear
  • Notice of Privacy Practices

  • Our Privacy Policy:

     

    BrightView is committed to providing you with quality behavioral healthcare services. An important part of that commitment is protecting your health information according to applicable law. This notice (“Notice of Privacy Practices”) describes your rights and our duties under Federal Law. Protected health information (“PHI”) is information about you, including demographic information, that may identify you and that relates to your past, present or future physical or mental health or condition; the provision of healthcare services; or the past, present or future payment for the provision of healthcare services to you.

     

    Our Duties:

     

    We are required by law to maintain the privacy of your PHI, provide you with notice of our legal duties and privacy practices with respect to your PHI, and to notify you following a breach of unsecured PHI related to you. We are required to abide by the terms of this Notice of Privacy Practices. This Notice of Privacy Practices is effective as of the date listed on the first page of this Notice of Privacy Practices. This Notice of Privacy Practices will remain in effect until it is revised. We are required to modify this Notice of Privacy Practices when there are material changes to your rights, our duties, or other practices contained herein.

     

    We reserve the right to change our privacy policy and practices and the terms of this Notice of Privacy Practices, consistent with applicable law and our current business processes, at any time. Any new Notice of Privacy Practices will be effective for all PHI that we maintain at that time. Notification of revisions of this Notice of Privacy Practices will be provided as follows upon request, electronically via our website or via other electronic means, or as posted in our place of business.

     

    In addition to the above, we have a duty to respond to your requests (e.g. those corresponding to your rights) in a timely and appropriate manner. We support and value your right to privacy and are committed to maintaining reasonable and appropriate safeguards for your PHI.

     

    Confidentiality of Substance Use Disorder Patient Records:

     

    The confidentiality of substance use disorder patient records maintained by us is also protected by Federal law and regulations. Generally, the law and regulations provide that:

     

    We may not disclose to a person outside the treatment center that you are present in the treatment center, that you are a patient of the treatment center, or any information identifying you as having or having had a substance use disorder.
    Except in specific, limited circumstances described in the federal regulations, we will not disclose any of your substance use disorder patient information to any person outside of the treatment center unless you consent in writing (as discussed below in “Authorization to use or Disclose Confidential Information”).
    Information related to your commission of a crime on the premises of the treatment center or against personnel of the treatment center is not protected; and
    Reports of suspected child abuse and neglect made under state law to appropriate state or local authorities is not protected.


    See 42 U.S.C. 290dd-3 and 42 U.S.C. 290ee-3 for Federal laws and 42 CFR part 2 for Federal regulations.

     

    Violation of the federal law and regulations by the treatment center is a crime. Suspected violations may be reported to United States Attorney for the judicial district in which the violation occurs as well as to the Substance Abuse and Mental Health Services (SAMHSA) office responsible for oversight of the treatment center.

     

    Uses and Disclosures

    Uses and disclosures of your PHI may be permitted, required, or authorized. The following categories describe various ways that we use and disclose PHI.

     

    Among BrightView Personnel: We may use or disclose information between or among personnel having a need for the information in connection with their duties that arise out of the provision of diagnosis, treatment, or referral for treatment of alcohol or drug abuse, provided such communication is (i) within the treatment center; or (ii) between the treatment center and BrightView. For example, our staff, including doctors, nurses, and clinicians, will use your PHI to provide your treatment care. Your PHI may be used in connection with billing statements we send you and in connection with tracking charges and credits to your account. Your PHI will be used to check for eligibility for insurance coverage and prepare claims for your insurance company where appropriate. We may use and disclose your PHI to conduct our healthcare business and to perform functions associated with our business activities, including accreditation and licensing.

     

    Secretary of Health and Human Services: We are required to disclose PHI to the Secretary of the U.S. Department of Health and Human Services when the Secretary is investigating or determining our compliance with the HIPAA Privacy Rules.

     

    Business Associates: We may disclose your PHI to Business Associates that are contracted by us to perform services on our behalf which may involve receipt, use or disclose of your PHI. All of our Business Associates must agree to: (i) protect the privacy of your PHI; (ii) use and disclose the information only for the purposes for which the Business Associate was engaged; (iii) be bound by 42 CFR Part 2; and (iv) if necessary, resist in judicial proceedings any efforts to obtain access to patient records except as permitted by law.

     

    Crimes on premises: We may disclose to law enforcement officers information that is directly related to the commission of a crime on the premises or against our personnel or to a threat to commit such a crime.

     

    Reports of suspected child abuse and neglect: We may disclose information required to report under state law incidents of suspected child abuse and neglect to the appropriate state or local authorities. However, we may not disclose the original patient records, including for civil or criminal proceedings which may arise out of the report of suspected child abuse and neglect, without consent.

     

    Court order: We may disclose information required by a court order, provided certain regulatory requirements are met.

     

    Emergency situations: We may disclose information to medical personnel for the purpose of treating you in an emergency.

     

    Research: We may use and disclose your information for research if certain requirements are met, such as approval by an Institutional Review Board.

     

    Audit and Evaluation Activities: We may disclose your information to persons conducting certain audit and evaluation activities, provided the person agrees to certain restrictions on disclosure of information.

     

    Reporting of Death: We may disclose your information related to cause of death to a public health authority that is authorized to receive such information.

     

    Dual Enrollment/Prescription Monitoring: By enrolling for Medication Assisted Treatment Services at this facility, your health information may be sent to other Opioid Treatment Programs within a 50-mile radius by facsimile to verify dual enrollment. The Maryland Prescription Drug Monitoring Program (PDMP) will also be utilized by BrightView staff to verify other prescribed controlled substances being dispensed to you.

     

    Authorization to use or disclose PHI

    Other than as stated above, we will not use or disclose your PHI other than with your written authorization. Subject to compliance with limited exceptions, we will not use or disclose psychotherapy notes, use or disclose your PHI for marketing purposes or sell your PHI unless you have signed an authorization. If you or your representative authorizes us to use or disclose your PHI, you may revoke that authorization in writing at any time to stop future uses or disclosures. We will honor oral revocations upon authenticating your identity until a written revocation is obtained. Your revocation will not affect any use or disclosures permitted by your authorization while it was in effect.

     

    Patient/Client Rights

    The following are the rights that you have regarding PHI that we maintain about you. Information regarding how to exercise those rights is also provided. Protecting your PHI is an important part of the services we provide you. We want to ensure that you have access to your PHI when you need it and that you clearly understand your rights as described below.

     

    Right to Notice

    You have the right to adequate notice of the uses and disclosures of your PHI, and our duties and responsibilities regarding same, as provided for herein. You have the right to request both a paper and electronic copy of this Notice. You may ask us to provide a copy of this notice at any time. You may obtain this notice on our website at www.americanaddictioncenters.org or from facility staff or our Privacy Official.

     

    Right of Access to Inspect and Copy

    You have the right to access, inspect and obtain a copy of your PHI for as long as we maintain it as required by law. This right may be restricted only in certain limited circumstances as dictated by applicable law. All requests for access to your PHI must be made in writing. Under a limited set of circumstances, we may deny your request. Any denial of a request to access will be communicated to you in writing. If you are denied access to your PHI, you may request that the denial be reviewed. Another licensed health care professional chosen by BrightView will review your request and the denial. The person conducting the review will not be the person who denied your request. We will comply with the decision made by the designated professional. If you are further denied, you have a right to have a denial reviewed by a licensed third-party healthcare professional (i.e. one not affiliated with us). We will comply with the decision made by the designated professional.

    We may charge a reasonable, cost-based fee for the copying and/or mailing process of your request. As to PHI which may be maintained in electronic form and format, you may request a copy to which you are otherwise entitled in that electronic form and format if it is readily producible, but if not, then in any readable form and format as we may agree (e.g. PDF). Your request may also include transmittal directions to another individual or entity.

     

    Right to Amend

    If you believe the PHI we have about you is incorrect or incomplete, you have the right to request that we amend your PHI for as long as it is maintained by us. The request must be made in writing, and you must provide a reason to support the requested amendment. Under certain circumstances we may deny your request to amend, including but not limited to, when the PHI: 1. was not created by us; 2. is excluded from access and inspection under applicable law; or 3. is accurate and complete. If we deny amendment, we will provide the rationale for denial to you in writing. You may write a statement of disagreement if your request is denied. This statement will be maintained as part of your PHI and will be included with any disclosure. If we accept the amendment, we will work with you to identify other healthcare stakeholders that require notification and provide the notification.

     

    Right to Request an Accounting of Disclosures

    We are required to create and maintain an accounting (list) of certain disclosures we make of your PHI. You have the right to request a copy of such an accounting during a time period specified by applicable law prior to the date on which the accounting is requested (up to six years). You must make any request for an accounting in writing.

    We are not required by law to record certain types of disclosures (such as disclosures made pursuant to an authorization signed by you), and a listing of these disclosures will not be provided. If you request this accounting more than once in a 12-month period, we may charge you a reasonable, cost-based fee for responding to these additional requests. We will notify you of the fee to be charged (if any) at the time of the request.

     

    Right to Request Restrictions

    You have the right to request restrictions or limitations on how we use and disclose your PHI for treatment, payment and operations. We are not required to agree to restrictions for treatment, payment and healthcare operations except in limited circumstances as described below.

    This request must be in writing. If we do agree to the restriction, we will comply with restriction going forward, unless you take affirmative steps to revoke it or we believe, in our professional judgment, that an emergency warrants circumventing the restriction in order to provide the appropriate care or unless the use or disclosure is otherwise permitted by law. In rare circumstances, we reserve the right to terminate a restriction that we have previously agreed to, but only after providing you notice of termination.

     

    Out-of-Pocket Payments

    If you have paid out-of-pocket (or in other words, you or someone besides your health plan has paid for your care) in full for a specific item or service, you have the right to request that your PHI with respect to that item or service not be disclosed to a health plan for purposes of payment or healthcare operations, and we are required by law to honor that request unless affirmatively terminated by you in writing and when the disclosures are not required by law. This request must be made in writing.

     

    Right to Confidential Communications

    You have the right to request that we communicate with you about your PHI and health matters by alternative means or alternative locations. Your request must be made in writing and must specify the alternative means or location. We will accommodate all reasonable requests consistent with our duty to ensure that your PHI is appropriately protected.

     

    Right to Notification of a Breach

    You have the right to be notified if we (or one of our Business Associates) discover a breach involving unsecured PHI.

     

    Right to Voice Concerns

    You have the right to file a complaint in writing with us or with the U.S. Department of Health and Human Services if you believe we have violated your privacy rights. Any complaints to us should be made in writing to our Privacy Official at the address listed below. We will not retaliate against you for filing a complaint.

     

    Questions, Requests for Information and Complaints

    For questions, requests for information, more information about our privacy policy or concerns, please contact us. Our company Privacy Official can be contacted at:

     

    BrightView

    Attn: Privacy Officer
    4600 Montgomery Road, Ste 400
    Cincinnati, OH 45212
    833.510.4357

     

    We support your right to privacy of your protected health information. You will not be retaliated against in any way if you choose to file a complaint with us or with the U.S. Department of Health and Human Services.

     

    If you believe your rights have been violated and would like to submit a complaint directly to the U.S. Department of Health & Human Services, then you may submit a formal written complaint to the following address:

     

    U.S. Department of Health & Human Services Office for Civil Rights
    200 Independence Avenue, S.W.
    Washington, D.C. 20201
    877.696.6775
    OCRMail@hhs.gov
    https://ocrportal.hhs.gov/ocr/smartscreen/main.jsf

     

    Patient Signed Consent

    I fully understand and agree to these policies and conditions. This supplements previous agreements I may have signed. A copy of this agreement is available upon request.

  • Clear
  • BrightView Alcohol and Drug Screens and Phlebotomy Services

  • It is the policy of BrightView to perform alcohol & drug screens on all patients via urinalysis. Patients will be screened at intake as well as periodically and randomly throughout treatment. A positive alcohol and/or drug screen is not cause for immediate termination from the program. However, a positive alcohol and/or drug screen could result in a change in a patient’s treatment plan. In some cases, urine specimens may be sent to outside laboratories for screening. If a specimen is sent to an outside laboratory and results in a positive screening, the positive result will be reviewed by BrightView staff with the patient. Alcohol and/or drug screens may not be covered by an insurance provider. If this is the case, the patient will be responsible for payment for the alcohol and/or drug screen.

     

    Refusal to consent to an alcohol or drug screen will be recorded as a “positive” result in the patient record. Repeated positive alcohol and/or drug screens can result in a change in treatment plan and/ or termination from the program.

     

    Consent for alcohol and drug screens:

    By consenting below, I am giving BrightView and any/all approved employees of BrightView permission to take a urine and/or saliva sample from me for evidence of alcohol and drug use. The purpose of obtaining the specimen is to monitor the possible use of illegal substances. I also understand that to maintain the integrity of the specimen I may be observed by a BrightView staff member while the urine specimens are obtained. However, I will be afforded a reasonable amount of privacy and will not be required nor allowed to expose my genitals at any time.


    Phlebotomy Services

    We may perform blood draws on the following during induction and routinely thereafter:

    • Comprehensive Metabolic Panel
    • Hepatitis B Surface Antigen with Reflex Confirmation
    • Hepatitis B Core Antibody
    • Hepatitis C Antibody with reflex to HCV RNA
    • Total RPR with reflex titer and confirmatory testing
    • Quantiferon TB gold
    • HIV 1/2 antigens/antibody fourth generation with reflex

  • Clear
  • Consent to Phlebotomy Services

  • Blood work will be ordered during the induction process for the following test. We are required to draw the following tests:

    • Hep C w/ Refl HCV
    • Hep B Surf AG w/conf
    • Quantiteron (R) PI
    • HIV 1/2 AG/AB 4 w/Refl
    • RPR Monito w/ Refl

    It is recommended that the following additional tests be preformed:

    • Heptatic Function Panel
    • Basic Metab Pnl
    • Hep B Surf AM QL
    • CBC Diff/Plt
    • Hep A AB, Total
    • Hep B Core AB, Total

    Testing is performed by a third party vendor. While most of these tests are covered by insurance, self-pay patients may receive a bill from a third party vendor for $140-$240.

  • Clear
  • Consent to Photograph

  • It is the policy of BrightView to photograph each patient for the purpose of identification during treatment. This photograph becomes a confidential component of the permanent record. I, the undersigned, do hereby authorize staff members of BrightView to photograph me while under their care.

  • Clear
  • Patient Rights

  • We would like to assure you that we will do everything possible to make your treatment experience as comfortable and productive as possible. To this end, we have adopted a Patient’s Bill of Rights. You can expect that you will always be treated with dignity and respect by all of those who work at this clinic, and you may be assured that your human rights will be protected. This facility shall not deny any person equal access to its facilities or services on the basis of race, color, religion, ancestry, sexual orientation, gender expression, national origin, or disability.

    PATIENTS SHALL:

    • Retain all civil rights and liberties except as provided by law.
    • Know the identity and professional status of individuals providing treatment services.
    • Have impartial access to treatment that is free of discrimination on the basis of age, race, creed, sex, ethnicity, color, national origin, marital status, sexual orientation, disability, or religion.
    • Be treated in a manner that is free from any formor type of humiliation, retaliation, abuse or neglect including financial abuse.
    • Give informed consent or refusal or expression of choice regarding service delivery; release of information; concurrent services; and composition of the service delivery team, when appropriate and as possible.
    • Have the right to inspect their own records subject to review of the record by BrightView who may remove materials determined to be detrimental to you.
    a. Have the right to request correction of inaccurate, irrelevant, outdated, or incomplete information in your record.
    b. Have the right to submit rebuttal data or memoranda to your record.
    • Have the right not to have treatment terminated without written notification from the Counselor and Operations Director stating the reasons for termination.
    • Have the right to appeal staff decisions regarding treatment decisions, including any decision to terminate treatment.
    • Have assurance of personal privacy.
    • Be treated with dignity and respect as a human being.
    • Have the right to refuse to participate in experimental or investigative research without written consent.
    • Be afforded the opportunity to have access to consultationwith a private physician, and referral to support and advocacy services and legal entities for appropriate representation.
    • Be treated under the least restrictive conditions and not be subjected to physical or pharmaceutical restraint.
    • Receive prompt evaluation and treatment and have results of treatment explained in understandable terms.
    • Have access to an interpreter when the patient does not speak or understand the
    predominate language of the community.
    • Have the right to refuse the use of medications, and other treatment procedures without prior consent.
    • Have the assurance of confidentiality regarding communication with the staff and all treatment documentation.

  • Clear
  • Maryland Department of Health: OPTUM

    AUTHORIZATION TO DISCLOSE SUBSTANCE USE TREATMENT INFORMATION FOR COORDINATION OF CARE
  • This Authorization to disclose is for the purpose of permitting the Maryland Medical Assistance Program (the Medicaid program), my substance use treatment provider, and any other providers identified in this form to coordinate my care so that it is more beneficial to me. By giving my consent, my Medicaid Managed Care Organization and any other providers specifically identified on this form will have access to information about substance use treatment I am receiving, which will help avoid conflicts in medication or treatment and improve the care I am receiving. By giving this consent, I may also gain access to other case management services offered through the Medicaid program.

     

    Please review and complete the consent here: OPTUM Consent

  • Ocean City, MD: Consent for the Release of Information under 42 C.F.R. PART 2

    Confidentiality of Substance Use Disorder Patient Records
  • This consent is ONLY for patients of the Ocean City location. If you are a patient of the Easton location, please visit the next page.

     

    If you a patient of the Ocean City location, please review and complete the consent here: Ocean City ROI

  • Easton, MD: Consent for the Release of Information under 42 C.F.R. PART 2

    Confidentiality of Substance Use Disorder Patient Records
  • This consent is ONLY for patients of the Easton location. If you are a patient of the Ocean City location, you do NOT need to complete the consent on this page.

     

    If you a patient of the Easton location, please review and complete the consent here: Easton ROI

  • Consent for the Release of Information under 42 C.F.R. PART 2

    Confidentiality of Substance Use Disorder Patient Records
  • If you would like to release or disclose your health information to additional persons or organizations, please complete the following consent: Release of Information

  • Medicaid Application

  • Please click the following Docusign link to complete the Medicaid Application for Medicaid and Medicare Savings Programs digitally.  If you're having trouble or would prefer a paper copy, please visit the front desk.  Complete the form digitally or via hard copy and return to the front desk before continuing.

    Digital Maryland Medicaid Application

  • Clear
  • Financial Assistance Application

  •  / /
  •  
  • You'll be required to send proof of three months of gross income for your household with this application.

    Gross income is total income before taxes are taken out, and includes but is not limited to:

    1. Three consecutive months of pay stubs or all pay stubs within the last three months if not employed for three months.
    2. Copy of previous year’s federal tax return.
    3. Social security, unemployment, alimony, child support, workers compensation award letter, or retirement income documentation in the form of a written statement, or verification of benefits from the applicable agency.
    4. Any other income statements.
  • If you reported zero total income, please have the following support statement completed by the person(s) helping to support you and/or your family.

  • Clear
  • Clear
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Browse Files
    Drag and drop files here
    Choose a file
    Cancelof
  • Patient Financial Responsibility Agreement

  • We appreciate the opportunity to be of service to you. Our office is dedicated to excellence in patient care. To maintain our high standards, we believe that it is important that we communicate our policies to you. Please take a moment to read and become familiar with these policies. Should you have any questions, the office staff is happy to help answer them. By presenting these policies in advance, we can avoid any surprises or misunderstandings. We appreciate your time and your understanding.

     

    Payment Responsibility: I have discussed responsibility for payment for treatment and I assume financial responsibility for myself and/or my family members. I understand that payment or co-payment is due at the time services are rendered unless special arrangements have been made. It is my responsibility to confirm coverage is provided by my insurance company or other provider.

     

    Charges for Additional Services: I understand that charges will be added to my account for other professional services rendered. These charges will be in increments of 15 minutes, or by encounter, and BrightView will always discuss additional charges with me. Other professional services include extended contact via email, consulting with other professionals (with my permission), preparation of records or treatment summaries, and the time spent performing any other service I may request.

     

    Appointments & Cancellations: I understand that I am required to provide at least 24 hours advance notice if unable to keep the scheduled appointment because the scheduled time slot has been reserved exclusively for me and/or my family members. Repeated missed appointments may result in termination of therapy. There may be a time when my therapist or physician may need to cancel my appointment for an emergency; BrightView will make every effort to reschedule me/my family in an appropriate time frame. This will be at no charge to me.

     

    I fully understand and agree to these policies and conditions. This supplements previous agreements I may have signed. A copy of this agreement is available upon request.

  • Clear
  • Acknowledgement of Patient Education and Materials

  • I acknowledge I have received education and/or materials (as applicable to my programming) on the following items and have been afforded the opportunity to ask any questions/clarifications:

    • Patient orientation to Program and Premises
    • Hours of operation and dispensing
    • Patient Rights and BrightView Grievance Procedures
    • BrightView’s Notice of Privacy Practices and written summary
    of Federal confidentiality laws
    • BrightView guidelines and rules/regulations
    • BrightView patient fees and billing procedures
    • Financial Assistance
    • Treatment options, including withdrawal management
    • Benefits and risks associated with each treatment option
    • Addiction treatment and pregnancy, including Neonatal Abstinence Syndrome
    and the risk and benefits of taking buprenorphine or methadone while pregnant, if
    applicable1
    • Resources for parenting/parenting skills
    • Use of voluntary long-acting reversible contraception, if applicable
    • Risk of exposure, prevention & treatment of chronic viral diseases including HIV, Hepatitis,
    Tuberculosis, and sexually transmitted infections
    • Expected therapeutic benefits and adverse effects of treatment medication
    • Risk for overdose, including drug interactions with the central nervous system depressants
    • Risk for overdose, including relapse after a period of abstinence from opioids
    • Overdose prevention and reversal agents
    • The disease of addiction
    • Information regarding the patient’s diagnosis
    • The effects of alcohol and other drug abuse
    • Family issues related to substance use disorder
    • Relapse prevention
    • Noncompliance and discharge procedures
    • Potential drug interactions
    • Toxicology testing and Phlebotomy Services Procedures
    • Take Home Medications
    • Crisis Services
    • Severe Weather Policy
    • Maryland Patient Handbook
    • Maryland Prescription Drug Monitoring Program (PDMP)
    • Medication Adherence Policy
    • Dual Enrollment Releases of Information
    • Consent for Alcohol or Drug Assessment and Treatment
    • Telemedicine Consent
    • Text Consent
    • Safe Storage of Take Home Medications (if applicable)

  • Clear
  • Should be Empty: